Peptides

Cat.No.	Name	Information
M50227	Pegmolesatide	Pegmolesatide is a synthetic peptide-based erythropoietic agent that may be used in studies related to anemia in chronic kidney disease.
M50223	Org-2766	Org-2766 is an analog and neurotrophic peptide of the adrenocorticotropic hormone ACTH (4-9) fragment and a melanocortin receptor 2 (MC2R) agonist.Org-2766 can be used in studies related to aging.
M50192	PAMP-12	PAMP-12 is an endogenous peptide and potent MRGPRX2 (MrgX2) agonist (EC50=20-50 nM) that induces hypotension by inhibiting catecholamine secretion from sympathetic nerve endings and adrenal chromaffin cells.
M49821	IPL344	IPL344 is a bioactive peptide that activates Akt pathway cell signaling and can be used in studies related to amyotrophic lateral sclerosis (ALS).
M49388	L-Alanyl-L-glutamine, for cell culture	L-Alanyl-L-glutamine, for cell culture is cell culture grade proglutide, a stabilized form of L-glutamine.
M45308	Casein Kinase II Receptor Peptide	Casein Kinase II Receptor Peptide is a substrate for Casein Kinase II (CK2) with a Km value of 500 µM.CASEIN KINASE II ACTIVITY can be used to determine casein kinase II activity in crude enzyme preparations.
M45255	HBP08	HBP08 is a high mobility group protein B1 (HMGB1) modulator that can be used in studies related to inflammation.
M45241	Ecallantide	Ecallantide is a potent, selective inhibitor of recombinant plasma kinin releasing enzyme that inhibits bradykinin production.
M45240	OK-101	OK-101 is a lipid-coupled chemokine peptide agonist of the ChemR23 g-protein-coupled receptor that can be used in studies related to neuropathic corneal pain (NCP).
M45231	Omomyc	Omomyc is a cell-penetrating peptide derived from the bHLH structural domain of Myc. When expressed in cells, Omomyc inhibits C-Myc-mediated transcription and suppresses cell proliferation.Omomyc competes with C-Myc for binding to Max, resulting in the formation of the Omomyc/Max complex, which competes with the endogenous c-Myc/Max heterodimer and ultimately inhibits transcriptional activation resulting in Myc target genes involved in proliferation and metabolism.
M45154	PN-943	PN-943 is a potentially first-in-class, orally active, specific α4β7 integrin antagonist peptide for studies related to inflammatory bowel disease (IBD).
M45132	Palopegteriparatide	Palopegteriparatide is a long-acting precursor compound of parathyroid hormone (PTH), as well as a calcium-sensitive receptor (CaSR) antagonist, and a parathyroid hormone receptor (PTH1R) modulator, and may be used in studies related to hypoparathyroidism (HP).
M45130	NNC0385-0434	NNC0385-0434 is a peptide based on the epidermal growth-factor-like domain A of the human LDLR peptide. NNC0385-0434 competitively binds free PCSK9 and subsequently prevents PCSK9 binding to the LDLR. NNC0385-0434 is an orally active peptide small molecule PCSK9 inhibitor for atherosclerosis-related studies.
M45056	RLS-0071	RLS-0071RLS-0071 is a dual-targeted peptide that modulates humoral and cellular immunity by inhibiting neutrophil effectors, including myeloperoxidase and neutrophil extracellular net trap (NET) formation.
M43909	LSTA1	LSTA1 is a novel tumor-targeting penetrating peptide that enables compounds to penetrate tumors more efficiently and accumulate in tumors by activating tumor-specific transport systems. It can be used in studies related to solid tumors.
M43811	IIAEK	IIAEK is a novel cholesterol-lowering pentapeptide derived from bovine milk β-lactoglobulin that targets intestinal alkaline phosphatase (IAP) and improves cholesterol metabolism through the specific activation of IAP and down-regulation of ABCA1. Sequence: Ile-Ile-Ala-Glu-Lys
M43365	YYRADDA	YYRADDA is a polypeptide.
M43364	Serylleucine	Serylleucine is a dipeptide.
M43363	Propionylglycine	Propionylglycine is a peptide.
M43362	NMB-1	NMB-1 is a conopeptide analogue.

Catalog

By Signaling Pathways

By Product Type

Signaling Pathways

Peptides

Get to Know Us

Customer Support

Resources

Contact Us